LLIN Evaluation in Uganda Project
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Sep 22, 2020
Trial Information
Current as of August 24, 2025
Completed
Keywords
ClinConnect Summary
This rigorous, cluster-randomised trial will evaluate the impact of long-lasting insecticidal nets (LLINs) distributed in Uganda through the 2020-21 national universal coverage campaign. A cluster has been defined as the catchment area of a Malaria Reference Centre (MRC). A total of 64 clusters have been included in the study, covering 32 high malaria burden districts in Uganda where IRS is not being implemented. Clusters have been randomised in a 1:1 ratio in blocks of two by district to receive one of two types of LLINs: (1) pyriproxyfen (PPF) LLINs (Royal Guard) \[n=32\] and (2) piperony...
Gender
ALL
Eligibility criteria
- • A) Primary outcome: All patients who present to the outpatient departments of the MRCs
- B) Community surveys for secondary outcomes:
- Inclusion Criteria:
- • At least one adult aged 18 years or older present
- • Adult is a usual resident who slept in the sampled household on the night before the survey
- • Agreement of the adult resident to provide informed consent for the household survey
- Exclusion Criteria:
- • Dwelling destroyed or not found
- • Household vacant
- • No adult resident home on more than 3 occasions
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kampala, , Uganda
Patients applied
Trial Officials
Sarah Staedke, MD, PhD
Principal Investigator
London School of Hygiene and Tropical Medicine
Moses Kamya, MBChB, MMed, PhD
Principal Investigator
Infectious Diseases Research Collaboration
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials